TALIS BIOMEDICAL CORP (TLIS) Institutional Ownership and Insiders Activity

TALIS BIOMEDICAL CORP (TLIS) is widely held by institutional investors, with 1 tracked firm reporting positions valued at approximately $1.11M based on SEC Form 13F filings for the quarter ended December 31, 2023.

Greenlight Capital is the largest disclosed holder, reporting approximately $1.11M in TLIS holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Greenlight Capital representing the majority of disclosed value.